Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
Ending the HIV epidemic faces daunting barriers, former WHO HIV chief warns

The difficulty of bringing the HIV epidemic “down to zero” should not be underestimated, Kevin de Cock, former director of HIV for the World Health Organization (WHO),

Published
30 November 2016
By
Gus Cairns
TB Alliance partners with PepsiCo to advance the fight for improved medicines for children

TB Alliance, a non-profit organization dedicated to developing better and faster cures for tuberculosis (TB), today announced a unique collaboration with food and beverage company PepsiCo designed to improve the treatment for children with TB. Many of today’s TB treatments are very bitter or unpleasant in taste, which when compounded with the long duration of treatment for TB, can lead to low tolerance and poor compliance – especially among children.

Published
28 October 2016
From
TB Alliance
47th Union World Conference on Lung Health: Even “free” TB treatment can come with catastrophic costs

Even before the costs of getting diagnosed, picked up in some high-tuberculosis incidence countries by patients themselves, and even before treatment brings its own costs, the financial toll of tuberculosis has already begun, a representative of the World Health Organization said today.

Published
26 October 2016
From
Science Speaks
TB drugs may be disrupted by botanical supplement, MU researchers find

MU researchers, working with scientists in Africa, discovered that a widely used African botanical supplement called Sutherlandia — traditionally taken to prevent or treat symptoms of infections — may actually disrupt the effectiveness of a common anti-tuberculosis drug, isoniazid.

Published
11 October 2016
From
Kansas City Star
Kenya to roll out child-friendly tuberculosis medicines nationwide

TB medicines specially adapted for children have been available since 2015, as a result of the UNITAID-funded STEP-TB project. In 2013 UNITAID committed 16.72 million dollars towards the implementation of the STEP-TB project, which brought together TB Alliance, and other partners to develop the first formulations of TB medicines that meets dosage guidelines set by the World Health Organization (WHO) in 2010.

Published
27 September 2016
From
UNITAID
WHO launches Target Regimen Profiles for TB treatment

Aimed at the pharmaceutical industry, research institutions, product development partnerships and donors, the new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

Published
08 September 2016
From
World Health Organization
TB Can Persist in Lungs Despite Treatment

The findings show that TB bacteria may persist in the lungs even after patients have finished treatment and are free of clinical symptoms. Although it is unclear how this might affect the risk of disease relapse, the study results underscore the need for new diagnostic methods and improved TB treatment strategies, according to the researchers.

Published
07 September 2016
From
National Institute of Allergy and Infectious Diseases
New WHO algorithm to prevent TB deaths in very ill people with HIV

The World Health Organization (WHO) has released a new diagnostic algorithm in order to reduce the likelihood of ‘seriously ill’ people with HIV dying of undiagnosed and

Published
23 August 2016
By
Theo Smart
Patients with TB and HIV should receive prompt coordinated treatment for both conditions

Tuberculosis is a leading killer of people with HIV, and providing therapy for both illnesses simultaneously saves lives - according to new guidelines on the treatment of drug-susceptible TB developed jointly by the American Thoracic Society, Centers for Disease Control and Prevention and Infectious Diseases Society of America. Treatment of TB in the presence of HIV infection is one of several special situations addressed in the new guidelines.

Published
15 August 2016
From
Eurekalert Inf Dis
A detectable CMV viral load could signal a high risk of mortality in older individuals hospitalised with HIV-associated TB

A study conducted in a cohort of hospitalised adults with HIV-associated tuberculosis (TB) co-infection from Khayelitsha found that having a detectable cytomegalovirus (CMV) viral load was associated

Published
09 August 2016
By
Theo Smart
← First12345...16Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.